{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:38Z","timestamp":1792783418071,"version":"4.5.0"},"reference-count":187,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Joint Innovation Fund Project of Chengdu University of TCM and Affiliated Hospitals","award":["LH20240205"],"award-info":[{"award-number":["LH20240205"]}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2022NSFSC0758"],"award-info":[{"award-number":["2022NSFSC0758"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12035-024-04584-9","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:36:45Z","timestamp":1731371805000},"page":"5273-5296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Parkinson's Disease and the Microbiota-Gut-Brain Axis: Metabolites, Mechanisms, and Innovative Therapeutic Strategies Targeting the Gut Microbiota"],"prefix":"10.1007","volume":"62","author":[{"given":"Zhao","family":"Ran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben-Rong","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Xin-Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan-Hong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Hong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"issue":"6","key":"4584_CR1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease: a review. Jama 323(6):548\u2013560. https:\/\/doi.org\/10.1001\/jama.2019.22360","journal-title":"Jama"},{"issue":"8","key":"4584_CR2","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"OB Tysnes","year":"2017","unstructured":"Tysnes OB, Storstein A (2017) Epidemiology of Parkinson\u2019s disease. J Neural Transm (Vienna) 124(8):901\u2013905. https:\/\/doi.org\/10.1007\/s00702-017-1686-y","journal-title":"J Neural Transm (Vienna)"},{"issue":"15","key":"4584_CR3","doi-asserted-by":"publisher","first-page":"8022","DOI":"10.3390\/ijms22158022","volume":"22","author":"S Vascellari","year":"2021","unstructured":"Vascellari S, Manzin A (2021) Parkinson\u2019s disease: a prionopathy? Int J Mol Sci 22(15):8022. https:\/\/doi.org\/10.3390\/ijms22158022","journal-title":"Int J Mol Sci"},{"key":"4584_CR4","doi-asserted-by":"publisher","first-page":"1213393","DOI":"10.1155\/2022\/1213393","volume":"2022","author":"P Mac\u00edas-Garc\u00eda","year":"2022","unstructured":"Mac\u00edas-Garc\u00eda P et al (2022) Neuropsychiatric symptoms in clinically defined Parkinson\u2019s disease: an updated review of literature. Behav Neurol 2022:1213393. https:\/\/doi.org\/10.1155\/2022\/1213393","journal-title":"Behav Neurol"},{"issue":"6","key":"4584_CR5","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/s1474-4422(15)00007-1","volume":"14","author":"A Fasano","year":"2015","unstructured":"Fasano A et al (2015) Gastrointestinal dysfunction in Parkinson\u2019s disease. Lancet Neurol 14(6):625\u201339. https:\/\/doi.org\/10.1016\/s1474-4422(15)00007-1","journal-title":"Lancet Neurol"},{"issue":"12","key":"4584_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11940-018-0539-9","volume":"20","author":"RF Pfeiffer","year":"2018","unstructured":"Pfeiffer RF (2018) Gastrointestinal dysfunction in Parkinson\u2019s disease. Curr Treat Options Neurol 20(12):54. https:\/\/doi.org\/10.1007\/s11940-018-0539-9","journal-title":"Curr Treat Options Neurol"},{"issue":"Suppl 1","key":"4584_CR7","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/jnc.13731","volume":"139","author":"A Bose","year":"2016","unstructured":"Bose A, Beal MF (2016) Mitochondrial dysfunction in Parkinson\u2019s disease. J Neurochem 139(Suppl 1):216\u2013231. https:\/\/doi.org\/10.1111\/jnc.13731","journal-title":"J Neurochem"},{"key":"4584_CR8","doi-asserted-by":"publisher","first-page":"3666327","DOI":"10.1155\/2021\/3666327","volume":"2021","author":"PC Chen","year":"2021","unstructured":"Chen PC et al (2021) The potential effects of oxidative stress-related plasma abnormal protein aggregate levels on brain volume and its neuropsychiatric consequences in Parkinson\u2019s disease. Oxid Med Cell Longev 2021:3666327. https:\/\/doi.org\/10.1155\/2021\/3666327","journal-title":"Oxid Med Cell Longev"},{"issue":"9","key":"4584_CR9","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.3390\/ijms22094676","volume":"22","author":"K Badanjak","year":"2021","unstructured":"Badanjak K et al (2021) The contribution of microglia to neuroinflammation in Parkinson\u2019s disease. Int J Mol Sci 22(9):4676. https:\/\/doi.org\/10.3390\/ijms22094676","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4584_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jphs.2020.07.011","volume":"144","author":"L Iovino","year":"2020","unstructured":"Iovino L, Tremblay ME, Civiero L (2020) Glutamate-induced excitotoxicity in Parkinson\u2019s disease: The role of glial cells. J Pharmacol Sci 144(3):151\u2013164. https:\/\/doi.org\/10.1016\/j.jphs.2020.07.011","journal-title":"J Pharmacol Sci"},{"issue":"2","key":"4584_CR11","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s40572-017-0143-2","volume":"4","author":"SM Fleming","year":"2017","unstructured":"Fleming SM (2017) Mechanisms of gene-environment interactions in Parkinson\u2019s disease. Curr Environ Health Rep 4(2):192\u2013199. https:\/\/doi.org\/10.1007\/s40572-017-0143-2","journal-title":"Curr Environ Health Rep"},{"issue":"6","key":"4584_CR12","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.3390\/ijms19061689","volume":"19","author":"V Caputi","year":"2018","unstructured":"Caputi V, Giron MC (2018) Microbiome-gut-brain axis and toll-like receptors in Parkinson\u2019s disease. Int J Mol Sci 19(6):1689. https:\/\/doi.org\/10.3390\/ijms19061689","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4584_CR13","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1172\/jci76304","volume":"125","author":"EA Mayer","year":"2015","unstructured":"Mayer EA, Tillisch K, Gupta A (2015) Gut\/brain axis and the microbiota. J Clin Invest 125(3):926\u201338. https:\/\/doi.org\/10.1172\/jci76304","journal-title":"J Clin Invest"},{"issue":"6","key":"4584_CR14","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR et al (2016) Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167(6):1469-1480.e12. https:\/\/doi.org\/10.1016\/j.cell.2016.11.018","journal-title":"Cell"},{"key":"4584_CR15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3389\/fnagi.2017.00441","volume":"9","author":"X Yang","year":"2017","unstructured":"Yang X et al (2017) Longitudinal analysis of fecal microbiome and pathologic processes in a rotenone induced mice model of Parkinson\u2019s disease. Front Aging Neurosci 9:441. https:\/\/doi.org\/10.3389\/fnagi.2017.00441","journal-title":"Front Aging Neurosci"},{"key":"4584_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.arr.2018.04.004","volume":"45","author":"MF Sun","year":"2018","unstructured":"Sun MF, Shen YQ (2018) Dysbiosis of gut microbiota and microbial metabolites in Parkinson\u2019s disease. Ageing Res Rev 45:53\u201361. https:\/\/doi.org\/10.1016\/j.arr.2018.04.004","journal-title":"Ageing Res Rev"},{"issue":"3","key":"4584_CR17","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans F et al (2015) Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov Disord 30(3):350\u20138. https:\/\/doi.org\/10.1002\/mds.26069","journal-title":"Mov Disord"},{"key":"4584_CR18","doi-asserted-by":"publisher","first-page":"134297","DOI":"10.1016\/j.neulet.2019.134297","volume":"707","author":"F Li","year":"2019","unstructured":"Li F et al (2019) Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson\u2019s disease. Neurosci Lett 707:134297. https:\/\/doi.org\/10.1016\/j.neulet.2019.134297","journal-title":"Neurosci Lett"},{"key":"4584_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger MM et al (2016) Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Parkinsonism Relat Disord 32:66\u201372. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.08.019","journal-title":"Parkinsonism Relat Disord"},{"key":"4584_CR20","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ebiom.2019.05.064","volume":"44","author":"VTE Aho","year":"2019","unstructured":"Aho VTE et al (2019) Gut microbiota in Parkinson\u2019s disease: temporal stability and relations to disease progression. EBioMed 44:691\u2013707. https:\/\/doi.org\/10.1016\/j.ebiom.2019.05.064","journal-title":"EBioMed"},{"issue":"1","key":"4584_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13073-017-0428-y","volume":"9","author":"JR Bedarf","year":"2017","unstructured":"Bedarf JR et al (2017) Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na\u00efve Parkinson\u2019s disease patients. Genome Med 9(1):39. https:\/\/doi.org\/10.1186\/s13073-017-0428-y","journal-title":"Genome Med"},{"issue":"1","key":"4584_CR22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/mds.27105","volume":"33","author":"A Heintz-Buschart","year":"2018","unstructured":"Heintz-Buschart A et al (2018) The nasal and gut microbiome in Parkinson\u2019s disease and idiopathic rapid eye movement sleep behavior disorder. Mov Disord 33(1):88\u201398. https:\/\/doi.org\/10.1002\/mds.27105","journal-title":"Mov Disord"},{"issue":"1","key":"4584_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3233\/jpd-191693","volume":"10","author":"G Vidal-Martinez","year":"2020","unstructured":"Vidal-Martinez G et al (2020) A pilot microbiota study in Parkinson\u2019s disease patients versus control subjects, and effects of FTY720 and FTY720-mitoxy therapies in Parkinsonian and multiple system atrophy mouse models. J Parkinsons Dis 10(1):185\u2013192. https:\/\/doi.org\/10.3233\/jpd-191693","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"4584_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-019-1528-y","volume":"16","author":"CH Lin","year":"2019","unstructured":"Lin CH et al (2019) Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson\u2019s disease. J Neuroinflammation 16(1):129. https:\/\/doi.org\/10.1186\/s12974-019-1528-y","journal-title":"J Neuroinflammation"},{"issue":"1","key":"4584_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41531-022-00351-6","volume":"8","author":"S Jo","year":"2022","unstructured":"Jo S et al (2022) Oral and gut dysbiosis leads to functional alterations in Parkinson\u2019s disease. NPJ Parkinsons Dis 8(1):87. https:\/\/doi.org\/10.1038\/s41531-022-00351-6","journal-title":"NPJ Parkinsons Dis"},{"issue":"7","key":"4584_CR26","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/mds.28052","volume":"35","author":"MS Cirstea","year":"2020","unstructured":"Cirstea MS et al (2020) Microbiota composition and metabolism are associated with gut function in Parkinson\u2019s disease. Mov Disord 35(7):1208\u20131217. https:\/\/doi.org\/10.1002\/mds.28052","journal-title":"Mov Disord"},{"issue":"5","key":"4584_CR27","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","volume":"32","author":"EM Hill-Burns","year":"2017","unstructured":"Hill-Burns EM et al (2017) Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome. Mov Disord 32(5):739\u2013749. https:\/\/doi.org\/10.1002\/mds.26942","journal-title":"Mov Disord"},{"key":"4584_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.parkreldis.2018.05.007","volume":"53","author":"A Lin","year":"2018","unstructured":"Lin A et al (2018) Gut microbiota in patients with Parkinson\u2019s disease in southern China. Parkinsonism Relat Disord 53:82\u201388. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.05.007","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"4584_CR29","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/mds.27581","volume":"34","author":"M Barichella","year":"2019","unstructured":"Barichella M et al (2019) Unraveling gut microbiota in Parkinson\u2019s disease and atypical parkinsonism. Mov Disord 34(3):396\u2013405. https:\/\/doi.org\/10.1002\/mds.27581","journal-title":"Mov Disord"},{"key":"4584_CR30","doi-asserted-by":"publisher","unstructured":"Vascellari S et al (2020) Gut microbiota and metabolome alterations associated with Parkinson's disease. mSystems 5(5):e00561\u201320. https:\/\/doi.org\/10.1128\/mSystems.00561-20","DOI":"10.1128\/mSystems.00561-20"},{"issue":"10","key":"4584_CR31","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26307","volume":"30","author":"A Keshavarzian","year":"2015","unstructured":"Keshavarzian A et al (2015) Colonic bacterial composition in Parkinson\u2019s disease. Mov Disord 30(10):1351\u201360. https:\/\/doi.org\/10.1002\/mds.26307","journal-title":"Mov Disord"},{"issue":"3","key":"4584_CR32","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ana.25982","volume":"89","author":"AH Tan","year":"2021","unstructured":"Tan AH et al (2021) Gut microbial ecosystem in Parkinson disease: new clinicobiological insights from multi-omics. Ann Neurol 89(3):546\u2013559. https:\/\/doi.org\/10.1002\/ana.25982","journal-title":"Ann Neurol"},{"key":"4584_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.parkreldis.2020.10.034","volume":"81","author":"F Zhang","year":"2020","unstructured":"Zhang F et al (2020) Altered gut microbiota in Parkinson\u2019s disease patients\/healthy spouses and its association with clinical features. Parkinsonism Relat Disord 81:84\u201388. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.10.034","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"4584_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12915-020-00775-7","volume":"18","author":"F Baldini","year":"2020","unstructured":"Baldini F et al (2020) Parkinson\u2019s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions. BMC Biol 18(1):62. https:\/\/doi.org\/10.1186\/s12915-020-00775-7","journal-title":"BMC Biol"},{"key":"4584_CR35","doi-asserted-by":"publisher","first-page":"105187","DOI":"10.1016\/j.micpath.2021.105187","volume":"160","author":"Z Yan","year":"2021","unstructured":"Yan Z et al (2021) Alterations of gut microbiota and metabolome with Parkinson\u2019s disease. Microb Pathog 160:105187. https:\/\/doi.org\/10.1016\/j.micpath.2021.105187","journal-title":"Microb Pathog"},{"key":"4584_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.brainres.2017.04.019","volume":"1667","author":"F Hopfner","year":"2017","unstructured":"Hopfner F et al (2017) Gut microbiota in Parkinson disease in a northern German cohort. Brain Res 1667:41\u201345. https:\/\/doi.org\/10.1016\/j.brainres.2017.04.019","journal-title":"Brain Res"},{"key":"4584_CR37","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbi.2018.02.016","volume":"70","author":"Y Qian","year":"2018","unstructured":"Qian Y et al (2018) Alteration of the fecal microbiota in Chinese patients with Parkinson\u2019s disease. Brain Behav Immun 70:194\u2013202. https:\/\/doi.org\/10.1016\/j.bbi.2018.02.016","journal-title":"Brain Behav Immun"},{"key":"4584_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuroscience.2021.10.011","volume":"480","author":"Z Li","year":"2022","unstructured":"Li Z et al (2022) Oral, nasal, and gut microbiota in Parkinson\u2019s disease. Neuroscience 480:65\u201378. https:\/\/doi.org\/10.1016\/j.neuroscience.2021.10.011","journal-title":"Neuroscience"},{"issue":"1","key":"4584_CR39","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41531-021-00254-y","volume":"7","author":"G Pal","year":"2021","unstructured":"Pal G et al (2021) Deep nasal sinus cavity microbiota dysbiosis in Parkinson\u2019s disease. NPJ Parkinsons Dis 7(1):111. https:\/\/doi.org\/10.1038\/s41531-021-00254-y","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"4584_CR40","doi-asserted-by":"publisher","first-page":"e0235821","DOI":"10.1128\/spectrum.02358-21","volume":"10","author":"M Arikan","year":"2022","unstructured":"Arikan M et al (2022) Axillary microbiota is associated with cognitive impairment in Parkinson\u2019s disease patients. Microbiol Spectr 10(1):e0235821. https:\/\/doi.org\/10.1128\/spectrum.02358-21","journal-title":"Microbiol Spectr"},{"key":"4584_CR41","doi-asserted-by":"publisher","unstructured":"Shen X et al (2017) Meta-analysis: association of Helicobacter pylori infection with Parkinson's diseases. Helicobacter 22(5):e12398. https:\/\/doi.org\/10.1111\/hel.12398","DOI":"10.1111\/hel.12398"},{"key":"4584_CR42","doi-asserted-by":"publisher","first-page":"112385","DOI":"10.1016\/j.ejmech.2020.112385","volume":"199","author":"L Wang","year":"2020","unstructured":"Wang L et al (2020) Identification and optimization of piperine analogues as neuroprotective agents for the treatment of Parkinson\u2019s disease via the activation of Nrf2\/keap1 pathway. Eur J Med Chem 199:112385. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112385","journal-title":"Eur J Med Chem"},{"key":"4584_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.clineuro.2017.07.003","volume":"160","author":"H Liu","year":"2017","unstructured":"Liu H et al (2017) Eradication of Helicobacter pylori infection might improve clinical status of patients with Parkinson\u2019s disease, especially on bradykinesia. Clin Neurol Neurosurg 160:101\u2013104. https:\/\/doi.org\/10.1016\/j.clineuro.2017.07.003","journal-title":"Clin Neurol Neurosurg"},{"key":"4584_CR44","doi-asserted-by":"publisher","first-page":"119767","DOI":"10.1016\/j.lfs.2021.119767","volume":"281","author":"F Bai","year":"2021","unstructured":"Bai F, Li X (2021) Association of Helicobacter pylori treatment with Parkinsonism and related disorders: a systematic review and meta-analysis. Life Sci 281:119767. https:\/\/doi.org\/10.1016\/j.lfs.2021.119767","journal-title":"Life Sci"},{"issue":"5","key":"4584_CR45","doi-asserted-by":"publisher","first-page":"e0251042","DOI":"10.1371\/journal.pone.0251042","volume":"16","author":"P Lolekha","year":"2021","unstructured":"Lolekha P, Sriphanom T, Vilaichone RK (2021) Helicobacter pylori eradication improves motor fluctuations in advanced Parkinson\u2019s disease patients: a prospective cohort study (HP-PD trial). PLoS One 16(5):e0251042. https:\/\/doi.org\/10.1371\/journal.pone.0251042","journal-title":"PLoS One"},{"issue":"1","key":"4584_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3233\/jpd-202298","volume":"11","author":"D Nyholm","year":"2021","unstructured":"Nyholm D, Hellstr\u00f6m PM (2021) Effects of Helicobacter pylori on levodopa pharmacokinetics. J Parkinsons Dis 11(1):61\u201369. https:\/\/doi.org\/10.3233\/jpd-202298","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"4584_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12979-023-00404-1","volume":"21","author":"B-R Wei","year":"2024","unstructured":"Wei B-R et al (2024) Helicobacter pylori infection and Parkinson\u2019s disease: etiology, pathogenesis and levodopa bioavailability. Immun Ageing 21(1):1. https:\/\/doi.org\/10.1186\/s12979-023-00404-1","journal-title":"Immun Ageing"},{"issue":"1","key":"4584_CR48","doi-asserted-by":"publisher","first-page":"19155","DOI":"10.1038\/s41598-023-45953-z","volume":"13","author":"MS Cirstea","year":"2023","unstructured":"Cirstea MS et al (2023) A novel pathway of levodopa metabolism by commensal Bifidobacteria. Sci Rep 13(1):19155. https:\/\/doi.org\/10.1038\/s41598-023-45953-z","journal-title":"Sci Rep"},{"issue":"1","key":"4584_CR49","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41467-019-08294-y","volume":"10","author":"SP van Kessel","year":"2019","unstructured":"van Kessel SP et al (2019) Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson\u2019s disease. Nat Commun 10(1):310. https:\/\/doi.org\/10.1038\/s41467-019-08294-y","journal-title":"Nat Commun"},{"key":"4584_CR50","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.1126\/science.aau6323","volume":"364","author":"V Maini Rekdal","year":"2019","unstructured":"Maini Rekdal V et al (2019) Discovery and inhibition of an interspecies gut bacterial pathway for levodopa metabolism. Science 364:6445. https:\/\/doi.org\/10.1126\/science.aau6323","journal-title":"Science"},{"key":"4584_CR51","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.3389\/fnins.2019.01184","volume":"13","author":"M Jin","year":"2019","unstructured":"Jin M et al (2019) Analysis of the gut microflora in patients with Parkinson\u2019s disease. Front Neurosci 13:1184. https:\/\/doi.org\/10.3389\/fnins.2019.01184","journal-title":"Front Neurosci"},{"issue":"11","key":"4584_CR52","doi-asserted-by":"publisher","first-page":"e0187307","DOI":"10.1371\/journal.pone.0187307","volume":"12","author":"T Minato","year":"2017","unstructured":"Minato T et al (2017) Progression of Parkinson\u2019s disease is associated with gut dysbiosis: two-year follow-up study. PLoS One 12(11):e0187307. https:\/\/doi.org\/10.1371\/journal.pone.0187307","journal-title":"PLoS One"},{"issue":"1","key":"4584_CR53","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5056\/jnm17105","volume":"24","author":"AT Nair","year":"2018","unstructured":"Nair AT et al (2018) Gut microbiota dysfunction as reliable non-invasive early diagnostic biomarkers in the pathophysiology of Parkinson\u2019s disease: a critical review. J Neurogastroenterol Motil 24(1):30\u201342. https:\/\/doi.org\/10.5056\/jnm17105","journal-title":"J Neurogastroenterol Motil"},{"key":"4584_CR54","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3389\/fimmu.2019.01486","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas D et al (2019) Corrigendum: Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol 10:1486. https:\/\/doi.org\/10.3389\/fimmu.2019.01486","journal-title":"Front Immunol"},{"key":"4584_CR55","doi-asserted-by":"publisher","unstructured":"Vacca M et al (2020) The controversial role of human gut Lachnospiraceae. Microorganisms 8(4):573. https:\/\/doi.org\/10.3390\/microorganisms8040573","DOI":"10.3390\/microorganisms8040573"},{"issue":"1","key":"4584_CR56","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3233\/jpd-202237","volume":"11","author":"MS Cirstea","year":"2021","unstructured":"Cirstea MS et al (2021) The gut mycobiome in Parkinson\u2019s disease. J Parkinsons Dis 11(1):153\u2013158. https:\/\/doi.org\/10.3233\/jpd-202237","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"4584_CR57","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41531-021-00244-0","volume":"7","author":"S Weis","year":"2021","unstructured":"Weis S et al (2021) Association between Parkinson\u2019s disease and the faecal eukaryotic microbiota. NPJ Parkinsons Dis 7(1):101. https:\/\/doi.org\/10.1038\/s41531-021-00244-0","journal-title":"NPJ Parkinsons Dis"},{"key":"4584_CR58","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.parkreldis.2022.01.005","volume":"95","author":"E De Pablo-Fernandez","year":"2022","unstructured":"De Pablo-Fernandez E et al (2022) The faecal metabolome and mycobiome in Parkinson\u2019s disease. Parkinsonism Relat Disord 95:65\u201369. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.01.005","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"4584_CR59","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.7150\/ijbs.42257","volume":"16","author":"D Pisa","year":"2020","unstructured":"Pisa D, Alonso R, Carrasco L (2020) Parkinson\u2019s disease: a comprehensive analysis of fungi and bacteria in brain tissue. Int J Biol Sci 16(7):1135\u20131152. https:\/\/doi.org\/10.7150\/ijbs.42257","journal-title":"Int J Biol Sci"},{"issue":"1","key":"4584_CR60","doi-asserted-by":"publisher","first-page":"10812","DOI":"10.1038\/s41598-018-29173-4","volume":"8","author":"G Tetz","year":"2018","unstructured":"Tetz G et al (2018) Parkinson\u2019s disease and bacteriophages as its overlooked contributors. Sci Rep 8(1):10812. https:\/\/doi.org\/10.1038\/s41598-018-29173-4","journal-title":"Sci Rep"},{"key":"4584_CR61","doi-asserted-by":"publisher","first-page":"840245","DOI":"10.3389\/fimmu.2022.840245","volume":"13","author":"E Dempsey","year":"2022","unstructured":"Dempsey E, Corr SC (2022) Lactobacillus spp. for gastrointestinal health: current and future perspectives. Front Immunol 13:840245. https:\/\/doi.org\/10.3389\/fimmu.2022.840245","journal-title":"Front Immunol"},{"issue":"9","key":"4584_CR62","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1007\/s00253-023-12489-1","volume":"107","author":"S Nie","year":"2023","unstructured":"Nie S et al (2023) The link between increased Desulfovibrio and disease severity in Parkinson\u2019s disease. Appl Microbiol Biotechnol 107(9):3033\u20133045. https:\/\/doi.org\/10.1007\/s00253-023-12489-1","journal-title":"Appl Microbiol Biotechnol"},{"key":"4584_CR63","doi-asserted-by":"publisher","first-page":"638867","DOI":"10.3389\/fimmu.2021.638867","volume":"12","author":"AL Miller","year":"2021","unstructured":"Miller AL et al (2021) Microbiome or infections: amyloid-containing biofilms as a trigger for complex human diseases. Front Immunol 12:638867. https:\/\/doi.org\/10.3389\/fimmu.2021.638867","journal-title":"Front Immunol"},{"issue":"10","key":"4584_CR64","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/gut.28.10.1221","volume":"28","author":"JH Cummings","year":"1987","unstructured":"Cummings JH et al (1987) Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28(10):1221\u20137. https:\/\/doi.org\/10.1136\/gut.28.10.1221","journal-title":"Gut"},{"issue":"8","key":"4584_CR65","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/mdc3.12840","volume":"6","author":"C Bullich","year":"2019","unstructured":"Bullich C et al (2019) Gut vibes in Parkinson\u2019s disease: the microbiota-gut-brain axis. Mov Disord Clin Pract 6(8):639\u2013651. https:\/\/doi.org\/10.1002\/mdc3.12840","journal-title":"Mov Disord Clin Pract"},{"key":"4584_CR66","doi-asserted-by":"publisher","first-page":"636545","DOI":"10.3389\/fnagi.2021.636545","volume":"13","author":"T Shen","year":"2021","unstructured":"Shen T et al (2021) The association between the gut microbiota and Parkinson\u2019s disease, a meta-analysis. Front Aging Neurosci 13:636545. https:\/\/doi.org\/10.3389\/fnagi.2021.636545","journal-title":"Front Aging Neurosci"},{"key":"4584_CR67","doi-asserted-by":"publisher","first-page":"111376","DOI":"10.1016\/j.exger.2021.111376","volume":"150","author":"Y Hou","year":"2021","unstructured":"Hou Y et al (2021) Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson\u2019s disease. Exp Gerontol 150:111376. https:\/\/doi.org\/10.1016\/j.exger.2021.111376","journal-title":"Exp Gerontol"},{"issue":"5","key":"4584_CR68","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/ndt\/gfy238","volume":"34","author":"A Gonzalez","year":"2019","unstructured":"Gonzalez A et al (2019) Sodium butyrate ameliorates insulin resistance and renal failure in CKD rats by modulating intestinal permeability and mucin expression. Nephrol Dial Transplant 34(5):783\u2013794. https:\/\/doi.org\/10.1093\/ndt\/gfy238","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"4584_CR69","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1007\/s10620-012-2259-4","volume":"57","author":"HB Wang","year":"2012","unstructured":"Wang HB et al (2012) Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription. Dig Dis Sci 57(12):3126\u201335. https:\/\/doi.org\/10.1007\/s10620-012-2259-4","journal-title":"Dig Dis Sci"},{"issue":"8","key":"4584_CR70","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.4049\/jimmunol.1700105","volume":"199","author":"L Zheng","year":"2017","unstructured":"Zheng L et al (2017) Microbial-derived butyrate promotes epithelial barrier function through IL-10 receptor-dependent repression of Claudin-2. J Immunol 199(8):2976\u20132984. https:\/\/doi.org\/10.4049\/jimmunol.1700105","journal-title":"J Immunol"},{"issue":"8","key":"4584_CR71","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/mds.29063","volume":"37","author":"X Yang","year":"2022","unstructured":"Yang X et al (2022) Parkinson\u2019s disease is associated with impaired gut-blood barrier for short-chain fatty acids. Mov Disord 37(8):1634\u20131643. https:\/\/doi.org\/10.1002\/mds.29063","journal-title":"Mov Disord"},{"issue":"263","key":"4584_CR72","doi-asserted-by":"publisher","first-page":"263ra158","DOI":"10.1126\/scitranslmed.3009759","volume":"6","author":"V Braniste","year":"2014","unstructured":"Braniste V et al (2014) The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med 6(263):263ra158. https:\/\/doi.org\/10.1126\/scitranslmed.3009759","journal-title":"Sci Transl Med"},{"issue":"8","key":"4584_CR73","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile B et al (2019) The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol 16(8):461\u2013478. https:\/\/doi.org\/10.1038\/s41575-019-0157-3","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"15","key":"4584_CR74","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1096\/fj.00-0359fje","volume":"14","author":"MD S\u00e4emann","year":"2000","unstructured":"S\u00e4emann MD et al (2000) Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. Faseb j 14(15):2380\u20132. https:\/\/doi.org\/10.1096\/fj.00-0359fje","journal-title":"Faseb j"},{"issue":"1","key":"4584_CR75","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1465-9921-11-33","volume":"11","author":"YF Ni","year":"2010","unstructured":"Ni YF et al (2010) Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice. Respir Res 11(1):33. https:\/\/doi.org\/10.1186\/1465-9921-11-33","journal-title":"Respir Res"},{"key":"4584_CR76","doi-asserted-by":"publisher","first-page":"112743","DOI":"10.1016\/j.fct.2021.112743","volume":"159","author":"AB Bayazid","year":"2022","unstructured":"Bayazid AB et al (2022) Sodium butyrate ameliorates neurotoxicity and exerts anti-inflammatory effects in high fat diet-fed mice. Food Chem Toxicol 159:112743. https:\/\/doi.org\/10.1016\/j.fct.2021.112743","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"4584_CR77","doi-asserted-by":"publisher","first-page":"111772","DOI":"10.1016\/j.yexcr.2019.111772","volume":"387","author":"CM Qiao","year":"2020","unstructured":"Qiao CM et al (2020) Sodium butyrate causes \u03b1-synuclein degradation by an Atg5-dependent and PI3K\/Akt\/mTOR-related autophagy pathway. Exp Cell Res 387(1):111772. https:\/\/doi.org\/10.1016\/j.yexcr.2019.111772","journal-title":"Exp Cell Res"},{"issue":"2","key":"4584_CR78","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1089\/ars.2010.3517","volume":"15","author":"LF Hu","year":"2011","unstructured":"Hu LF et al (2011) Hydrogen sulfide: neurophysiology and neuropathology. Antioxid Redox Signal 15(2):405\u201319. https:\/\/doi.org\/10.1089\/ars.2010.3517","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"4584_CR79","doi-asserted-by":"publisher","first-page":"R1479","DOI":"10.1152\/ajpregu.90566.2008","volume":"295","author":"J Furne","year":"2008","unstructured":"Furne J, Saeed A, Levitt MD (2008) Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values. Am J Physiol Regul Integr Comp Physiol 295(5):R1479-85. https:\/\/doi.org\/10.1152\/ajpregu.90566.2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"7","key":"4584_CR80","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1080\/01616412.2017.1390903","volume":"40","author":"M Sarukhani","year":"2018","unstructured":"Sarukhani M et al (2018) Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson\u2019s disease: behavioral, histological and biochemical studies. Neurol Res 40(7):523\u2013531. https:\/\/doi.org\/10.1080\/01616412.2017.1390903","journal-title":"Neurol Res"},{"issue":"7","key":"4584_CR81","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.4103\/1673-5374.301026","volume":"16","author":"M Wang","year":"2021","unstructured":"Wang M et al (2021) Hydrogen sulfide enhances adult neurogenesis in a mouse model of Parkinson\u2019s disease. Neural Regen Res 16(7):1353\u20131358. https:\/\/doi.org\/10.4103\/1673-5374.301026","journal-title":"Neural Regen Res"},{"key":"4584_CR82","doi-asserted-by":"publisher","first-page":"105187","DOI":"10.1016\/j.neuint.2021.105187","volume":"150","author":"XO Hou","year":"2021","unstructured":"Hou XO et al (2021) AMPK S-sulfuration contributes to H(2)S donors-induced AMPK phosphorylation and autophagy activation in dopaminergic cells. Neurochem Int 150:105187. https:\/\/doi.org\/10.1016\/j.neuint.2021.105187","journal-title":"Neurochem Int"},{"key":"4584_CR83","doi-asserted-by":"publisher","first-page":"2792348","DOI":"10.1155\/2022\/2792348","volume":"2022","author":"Q Tian","year":"2022","unstructured":"Tian Q et al (2022) Hydrogen sulfide attenuates the cognitive dysfunction in Parkinson\u2019s disease rats via promoting hippocampal microglia M2 polarization by enhancement of hippocampal warburg effect. Oxid Med Cell Longev 2022:2792348. https:\/\/doi.org\/10.1155\/2022\/2792348","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"4584_CR84","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13024-016-0135-y","volume":"11","author":"A Kumar","year":"2016","unstructured":"Kumar A, Ganini D, Mason RP (2016) Role of cytochrome c in \u03b1-synuclein radical formation: implications of \u03b1-synuclein in neuronal death in Maneb- and paraquat-induced model of Parkinson\u2019s disease. Mol Neurodegener 11(1):70. https:\/\/doi.org\/10.1186\/s13024-016-0135-y","journal-title":"Mol Neurodegener"},{"issue":"4","key":"4584_CR85","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/j.1471-4159.2004.02918.x","volume":"92","author":"R Clayton","year":"2005","unstructured":"Clayton R, Clark JB, Sharpe M (2005) Cytochrome c release from rat brain mitochondria is proportional to the mitochondrial functional deficit: implications for apoptosis and neurodegenerative disease. J Neurochem 92(4):840\u20139. https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02918.x","journal-title":"J Neurochem"},{"issue":"41","key":"4584_CR86","doi-asserted-by":"publisher","first-page":"28849","DOI":"10.1074\/jbc.274.41.28849","volume":"274","author":"M Hashimoto","year":"1999","unstructured":"Hashimoto M et al (1999) Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease. J Biol Chem 274(41):28849\u201352. https:\/\/doi.org\/10.1074\/jbc.274.41.28849","journal-title":"J Biol Chem"},{"issue":"1","key":"4584_CR87","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1096\/fj.06-6255com","volume":"21","author":"R Baskar","year":"2007","unstructured":"Baskar R, Li L, Moore PK (2007) Hydrogen sulfide-induces DNA damage and changes in apoptotic gene expression in human lung fibroblast cells. Faseb j 21(1):247\u201355. https:\/\/doi.org\/10.1096\/fj.06-6255com","journal-title":"Faseb j"},{"issue":"1","key":"4584_CR88","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1600-0765.2008.01199.x","volume":"45","author":"B Calenic","year":"2010","unstructured":"Calenic B et al (2010) Oral malodorous compound triggers mitochondrial-dependent apoptosis and causes genomic DNA damage in human gingival epithelial cells. J Periodontal Res 45(1):31\u20137. https:\/\/doi.org\/10.1111\/j.1600-0765.2008.01199.x","journal-title":"J Periodontal Res"},{"key":"4584_CR89","doi-asserted-by":"publisher","unstructured":"Murros KE (2022) Hydrogen sulfide produced by gut bacteria may induce Parkinson's disease. Cells 11(6):978. https:\/\/doi.org\/10.3390\/cells11060978","DOI":"10.3390\/cells11060978"},{"issue":"1","key":"4584_CR90","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/jnc.14312","volume":"145","author":"Y Xiao","year":"2018","unstructured":"Xiao Y et al (2018) Iron promotes \u03b1-synuclein aggregation and transmission by inhibiting TFEB-mediated autophagosome-lysosome fusion. J Neurochem 145(1):34\u201350. https:\/\/doi.org\/10.1111\/jnc.14312","journal-title":"J Neurochem"},{"key":"4584_CR91","doi-asserted-by":"publisher","unstructured":"Klein RD et al (2018) Structure-function analysis of the curli accessory protein CsgE defines surfaces essential for coordinating amyloid fiber formation. mBio 9(4):e01349\u201318. https:\/\/doi.org\/10.1128\/mBio.01349-18","DOI":"10.1128\/mBio.01349-18"},{"key":"4584_CR92","doi-asserted-by":"publisher","unstructured":"Barnhart MM, Chapman MR (2006) Curli biogenesis and function. Annu Rev Microbiol 60:131\u201347. https:\/\/doi.org\/10.1146\/annurev.micro.60.080805.142106","DOI":"10.1146\/annurev.micro.60.080805.142106"},{"key":"4584_CR93","doi-asserted-by":"publisher","unstructured":"Wang C et al (2021) Genome-wide screen identifies curli amyloid fibril as a bacterial component promoting host neurodegeneration. Proc Natl Acad Sci USA 118(34):e2106504118. https:\/\/doi.org\/10.1073\/pnas.2106504118","DOI":"10.1073\/pnas.2106504118"},{"issue":"1","key":"4584_CR94","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1365-2958.2005.04825.x","volume":"58","author":"C T\u00fckel","year":"2005","unstructured":"T\u00fckel C et al (2005) CsgA is a pathogen-associated molecular pattern of Salmonella enterica serotype Typhimurium that is recognized by Toll-like receptor 2. Mol Microbiol 58(1):289\u2013304. https:\/\/doi.org\/10.1111\/j.1365-2958.2005.04825.x","journal-title":"Mol Microbiol"},{"issue":"2","key":"4584_CR95","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1086\/315233","volume":"181","author":"Z Bian","year":"2000","unstructured":"Bian Z et al (2000) Expression of and cytokine activation by Escherichia coli curli fibers in human sepsis. J Infect Dis 181(2):602\u201312. https:\/\/doi.org\/10.1086\/315233","journal-title":"J Infect Dis"},{"key":"4584_CR96","doi-asserted-by":"publisher","unstructured":"Sampson TR et al (2020) A gut bacterial amyloid promotes \u03b1-synuclein aggregation and motor impairment in mice. Elife 9:e53111. https:\/\/doi.org\/10.7554\/eLife.53111","DOI":"10.7554\/eLife.53111"},{"issue":"7","key":"4584_CR97","doi-asserted-by":"publisher","first-page":"102088","DOI":"10.1016\/j.jbc.2022.102088","volume":"298","author":"SS Bhoite","year":"2022","unstructured":"Bhoite SS et al (2022) Mechanistic insights into accelerated \u03b1-synuclein aggregation mediated by human microbiome-associated functional amyloids. J Biol Chem 298(7):102088. https:\/\/doi.org\/10.1016\/j.jbc.2022.102088","journal-title":"J Biol Chem"},{"key":"4584_CR98","doi-asserted-by":"publisher","first-page":"34477","DOI":"10.1038\/srep34477","volume":"6","author":"SG Chen","year":"2016","unstructured":"Chen SG et al (2016) Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans. Sci Rep 6:34477. https:\/\/doi.org\/10.1038\/srep34477","journal-title":"Sci Rep"},{"key":"4584_CR99","doi-asserted-by":"publisher","first-page":"875349","DOI":"10.3389\/fphar.2022.875349","volume":"13","author":"C Wang","year":"2022","unstructured":"Wang C, Zheng C (2022) Using Caenorhabditis elegans to model therapeutic interventions of neurodegenerative diseases targeting microbe-host interactions. Front Pharmacol 13:875349. https:\/\/doi.org\/10.3389\/fphar.2022.875349","journal-title":"Front Pharmacol"},{"key":"4584_CR100","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jff.2015.09.019","volume":"19","author":"A Gonz\u00e1lez-Sarr\u00edas","year":"2015","unstructured":"Gonz\u00e1lez-Sarr\u00edas A et al (2015) Identifying the limits for ellagic acid bioavailability: a crossover pharmacokinetic study in healthy volunteers after consumption of pomegranate extracts. J Funct Foods 19:225\u2013235. https:\/\/doi.org\/10.1016\/j.jff.2015.09.019","journal-title":"J Funct Foods"},{"key":"4584_CR101","doi-asserted-by":"publisher","first-page":"3848084","DOI":"10.1155\/2022\/3848084","volume":"2022","author":"J Sharifi-Rad","year":"2022","unstructured":"Sharifi-Rad J et al (2022) Ellagic acid: a review on its natural sources, chemical stability, and therapeutic potential. Oxid Med Cell Longev 2022:3848084. https:\/\/doi.org\/10.1155\/2022\/3848084","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"4584_CR102","doi-asserted-by":"publisher","first-page":"e43156","DOI":"10.7759\/cureus.43156","volume":"15","author":"P Harper","year":"2023","unstructured":"Harper P (2023) A review of the dietary intake, bioavailability and health benefits of ellagic acid (EA) with a primary focus on its anti-cancer properties. Cureus 15(8):e43156. https:\/\/doi.org\/10.7759\/cureus.43156","journal-title":"Cureus"},{"key":"4584_CR103","doi-asserted-by":"publisher","unstructured":"Tom\u00e1s-Barber\u00e1n FA et al (2017) Urolithins, the rescue of\u00a0 \u201cold\u201d\u00a0metabolites to understand a \u201cnew\u201d\u00a0concept: metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status. Mol Nutr Food Res 61(1):1500901. https:\/\/doi.org\/10.1002\/mnfr.201500901","DOI":"10.1002\/mnfr.201500901"},{"issue":"7","key":"4584_CR104","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.molmed.2021.04.009","volume":"27","author":"D D'Amico","year":"2021","unstructured":"D\u2019Amico D et al (2021) Impact of the natural compound urolithin a on health, disease, and aging. Trends Mol Med 27(7):687\u2013699. https:\/\/doi.org\/10.1016\/j.molmed.2021.04.009","journal-title":"Trends Mol Med"},{"issue":"9","key":"4584_CR105","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.4103\/1673-5374.335163","volume":"17","author":"QY Gong","year":"2022","unstructured":"Gong QY et al (2022) Urolithin A alleviates blood-brain barrier disruption and attenuates neuronal apoptosis following traumatic brain injury in mice. Neural Regen Res 17(9):2007\u20132013. https:\/\/doi.org\/10.4103\/1673-5374.335163","journal-title":"Neural Regen Res"},{"issue":"11","key":"4584_CR106","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.1039\/d2fo00552b","volume":"13","author":"M Romo-Vaquero","year":"2022","unstructured":"Romo-Vaquero M et al (2022) Urolithins: potential biomarkers of gut dysbiosis and disease stage in Parkinson\u2019s patients. Food Funct 13(11):6306\u20136316. https:\/\/doi.org\/10.1039\/d2fo00552b","journal-title":"Food Funct"},{"key":"4584_CR107","doi-asserted-by":"publisher","first-page":"108963","DOI":"10.1016\/j.neuropharm.2022.108963","volume":"207","author":"J Qiu","year":"2022","unstructured":"Qiu J et al (2022) Urolithin A promotes mitophagy and suppresses NLRP3 inflammasome activation in lipopolysaccharide-induced BV2 microglial cells and MPTP-induced Parkinson\u2019s disease model. Neuropharmacology 207:108963. https:\/\/doi.org\/10.1016\/j.neuropharm.2022.108963","journal-title":"Neuropharmacology"},{"issue":"1","key":"4584_CR108","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1039\/d1fo02534a","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J et al (2022) Urolithin A protects dopaminergic neurons in experimental models of Parkinson\u2019s disease by promoting mitochondrial biogenesis through the SIRT1\/PGC-1\u03b1 signaling pathway. Food Funct 13(1):375\u2013385. https:\/\/doi.org\/10.1039\/d1fo02534a","journal-title":"Food Funct"},{"issue":"1","key":"4584_CR109","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41467-018-07859-7","volume":"10","author":"R Singh","year":"2019","unstructured":"Singh R et al (2019) Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway. Nat Commun 10(1):89. https:\/\/doi.org\/10.1038\/s41467-018-07859-7","journal-title":"Nat Commun"},{"issue":"8","key":"4584_CR110","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/bph.13959","volume":"175","author":"S Subramaniam","year":"2018","unstructured":"Subramaniam S, Fletcher C (2018) Trimethylamine N-oxide: breathe new life. Br J Pharmacol 175(8):1344\u20131353. https:\/\/doi.org\/10.1111\/bph.13959","journal-title":"Br J Pharmacol"},{"issue":"1","key":"4584_CR111","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1161\/hypertensionaha.120.14759","volume":"76","author":"VE Brunt","year":"2020","unstructured":"Brunt VE et al (2020) Trimethylamine-N-oxide promotes age-related vascular oxidative stress and endothelial dysfunction in mice and healthy humans. Hypertension 76(1):101\u2013112. https:\/\/doi.org\/10.1161\/hypertensionaha.120.14759","journal-title":"Hypertension"},{"issue":"11","key":"4584_CR112","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1002\/mds.28246","volume":"35","author":"SJ Chen","year":"2020","unstructured":"Chen SJ et al (2020) The gut metabolite trimethylamine N-oxide is associated with Parkinson\u2019s disease severity and progression. Mov Disord 35(11):2115\u20132116. https:\/\/doi.org\/10.1002\/mds.28246","journal-title":"Mov Disord"},{"key":"4584_CR113","doi-asserted-by":"publisher","first-page":"111090","DOI":"10.1016\/j.nut.2020.111090","volume":"83","author":"SJ Chung","year":"2021","unstructured":"Chung SJ et al (2021) Gut microbiota-derived metabolite trimethylamine N-oxide as a biomarker in early Parkinson\u2019s disease. Nutrition 83:111090. https:\/\/doi.org\/10.1016\/j.nut.2020.111090","journal-title":"Nutrition"},{"issue":"9","key":"4584_CR114","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.1007\/s12035-023-03392-x","volume":"60","author":"CM Qiao","year":"2023","unstructured":"Qiao CM et al (2023) Orally induced high serum level of trimethylamine N-oxide worsened glial reaction and neuroinflammation on MPTP-induced acute Parkinson\u2019s disease model mice. Mol Neurobiol 60(9):5137\u20135154. https:\/\/doi.org\/10.1007\/s12035-023-03392-x","journal-title":"Mol Neurobiol"},{"issue":"5","key":"4584_CR115","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3390\/brainsci13050790","volume":"13","author":"W Quan","year":"2023","unstructured":"Quan W et al (2023) Trimethylamine N-oxide exacerbates neuroinflammation and motor dysfunction in an acute MPTP mice model of Parkinson\u2019s disease. Brain Sci 13(5):790. https:\/\/doi.org\/10.3390\/brainsci13050790","journal-title":"Brain Sci"},{"issue":"2","key":"4584_CR116","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/medsci9020044","volume":"9","author":"NA Sagar","year":"2021","unstructured":"Sagar NA et al (2021) Polyamines: functions, metabolism, and role in human disease management. Med Sci (Basel) 9(2):44. https:\/\/doi.org\/10.3390\/medsci9020044","journal-title":"Med Sci (Basel)"},{"key":"4584_CR117","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev-biochem-071322-021330","volume":"92","author":"S Vrijsen","year":"2023","unstructured":"Vrijsen S et al (2023) Polyamines in Parkinson\u2019s disease: balancing between neurotoxicity and neuroprotection. Annu Rev Biochem 92:435\u2013464. https:\/\/doi.org\/10.1146\/annurev-biochem-071322-021330","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"4584_CR118","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1348-0421.2007.tb03887.x","volume":"51","author":"M Matsumoto","year":"2007","unstructured":"Matsumoto M, Benno Y (2007) The relationship between microbiota and polyamine concentration in the human intestine: a pilot study. Microbiol Immunol 51(1):25\u201335. https:\/\/doi.org\/10.1111\/j.1348-0421.2007.tb03887.x","journal-title":"Microbiol Immunol"},{"issue":"2","key":"4584_CR119","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.mrfmmm.2004.07.016","volume":"568","author":"M Matsumoto","year":"2004","unstructured":"Matsumoto M, Benno Y (2004) Consumption of Bifidobacterium lactis LKM512 yogurt reduces gut mutagenicity by increasing gut polyamine contents in healthy adult subjects. Mutat Res 568(2):147\u201353. https:\/\/doi.org\/10.1016\/j.mrfmmm.2004.07.016","journal-title":"Mutat Res"},{"issue":"1","key":"4584_CR120","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1348-0421.2007.tb03888.x","volume":"51","author":"M Matsumoto","year":"2007","unstructured":"Matsumoto M, Kakizoe K, Benno Y (2007) Comparison of fecal microbiota and polyamine concentration in adult patients with intractable atopic dermatitis and healthy adults. Microbiol Immunol 51(1):37\u201346. https:\/\/doi.org\/10.1111\/j.1348-0421.2007.tb03888.x","journal-title":"Microbiol Immunol"},{"key":"4584_CR121","doi-asserted-by":"publisher","first-page":"1094258","DOI":"10.3389\/fendo.2022.1094258","volume":"13","author":"TI Bui","year":"2022","unstructured":"Bui TI et al (2022) Probiotic induced synthesis of microbiota polyamine as a nutraceutical for metabolic syndrome and obesity-related type 2 diabetes. Front Endocrinol (Lausanne) 13:1094258. https:\/\/doi.org\/10.3389\/fendo.2022.1094258","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4584_CR122","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.neuint.2018.02.010","volume":"116","author":"S Sharma","year":"2018","unstructured":"Sharma S, Kumar P, Deshmukh R (2018) Neuroprotective potential of spermidine against rotenone induced Parkinson\u2019s disease in rats. Neurochem Int 116:104\u2013111. https:\/\/doi.org\/10.1016\/j.neuint.2018.02.010","journal-title":"Neurochem Int"},{"issue":"24","key":"4584_CR123","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.4161\/15384101.2014.973309","volume":"13","author":"S B\u00fcttner","year":"2014","unstructured":"B\u00fcttner S et al (2014) Spermidine protects against \u03b1-synuclein neurotoxicity. Cell Cycle 13(24):3903\u20138. https:\/\/doi.org\/10.4161\/15384101.2014.973309","journal-title":"Cell Cycle"},{"issue":"2","key":"4584_CR124","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/ana.25516","volume":"86","author":"S Saiki","year":"2019","unstructured":"Saiki S et al (2019) A metabolic profile of polyamines in parkinson disease: a promising biomarker. Ann Neurol 86(2):251\u2013263. https:\/\/doi.org\/10.1002\/ana.25516","journal-title":"Ann Neurol"},{"key":"4584_CR125","doi-asserted-by":"publisher","first-page":"102083","DOI":"10.1016\/j.npep.2020.102083","volume":"83","author":"I Ghosh","year":"2020","unstructured":"Ghosh I et al (2020) Spermidine, an autophagy inducer, as a therapeutic strategy in neurological disorders. Neuropeptides 83:102083. https:\/\/doi.org\/10.1016\/j.npep.2020.102083","journal-title":"Neuropeptides"},{"key":"4584_CR126","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40478-015-0196-0","volume":"3","author":"T Clairembault","year":"2015","unstructured":"Clairembault T et al (2015) Structural alterations of the intestinal epithelial barrier in Parkinson\u2019s disease. Acta Neuropathol Commun 3:12. https:\/\/doi.org\/10.1186\/s40478-015-0196-0","journal-title":"Acta Neuropathol Commun"},{"issue":"12","key":"4584_CR127","doi-asserted-by":"publisher","first-page":"e28032","DOI":"10.1371\/journal.pone.0028032","volume":"6","author":"CB Forsyth","year":"2011","unstructured":"Forsyth CB et al (2011) Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease. PLoS One 6(12):e28032. https:\/\/doi.org\/10.1371\/journal.pone.0028032","journal-title":"PLoS One"},{"issue":"3","key":"4584_CR128","doi-asserted-by":"publisher","first-page":"e16876","DOI":"10.1371\/journal.pone.0016876","volume":"6","author":"MW van Passel","year":"2011","unstructured":"van Passel MW et al (2011) The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLoS One 6(3):e16876. https:\/\/doi.org\/10.1371\/journal.pone.0016876","journal-title":"PLoS One"},{"key":"4584_CR129","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbi.2016.02.020","volume":"56","author":"EE Fr\u00f6hlich","year":"2016","unstructured":"Fr\u00f6hlich EE et al (2016) Cognitive impairment by antibiotic-induced gut dysbiosis: analysis of gut microbiota-brain communication. Brain Behav Immun 56:140\u201355. https:\/\/doi.org\/10.1016\/j.bbi.2016.02.020","journal-title":"Brain Behav Immun"},{"issue":"2","key":"4584_CR130","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10571-021-01066-7","volume":"42","author":"N Dogra","year":"2022","unstructured":"Dogra N, Mani RJ, Katare DP (2022) The gut-brain axis: two ways signaling in Parkinson\u2019s disease. Cell Mol Neurobiol 42(2):315\u2013332. https:\/\/doi.org\/10.1007\/s10571-021-01066-7","journal-title":"Cell Mol Neurobiol"},{"issue":"22","key":"4584_CR131","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.3390\/ijms21228421","volume":"21","author":"C Marogianni","year":"2020","unstructured":"Marogianni C et al (2020) Neurodegeneration and inflammation-an interesting interplay in Parkinson\u2019s disease. Int J Mol Sci 21(22):8421. https:\/\/doi.org\/10.3390\/ijms21228421","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4584_CR132","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/iub.2510","volume":"73","author":"M Pascual","year":"2021","unstructured":"Pascual M et al (2021) Toll-like receptors in neuroinflammation, neurodegeneration, and alcohol-induced brain damage. IUBMB Life 73(7):900\u2013915. https:\/\/doi.org\/10.1002\/iub.2510","journal-title":"IUBMB Life"},{"issue":"376","key":"4584_CR133","doi-asserted-by":"publisher","first-page":"ra45","DOI":"10.1126\/scisignal.2005965","volume":"8","author":"SG Daniele","year":"2015","unstructured":"Daniele SG et al (2015) Activation of MyD88-dependent TLR1\/2 signaling by misfolded \u03b1-synuclein, a protein linked to neurodegenerative disorders. Sci Signal 8(376):ra45. https:\/\/doi.org\/10.1126\/scisignal.2005965","journal-title":"Sci Signal"},{"issue":"1","key":"4584_CR134","doi-asserted-by":"publisher","first-page":"e55375","DOI":"10.1371\/journal.pone.0055375","volume":"8","author":"G Codolo","year":"2013","unstructured":"Codolo G et al (2013) Triggering of inflammasome by aggregated \u03b1-synuclein, an inflammatory response in synucleinopathies. PLoS One 8(1):e55375. https:\/\/doi.org\/10.1371\/journal.pone.0055375","journal-title":"PLoS One"},{"issue":"3","key":"4584_CR135","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/glia.22437","volume":"61","author":"L Fellner","year":"2013","unstructured":"Fellner L et al (2013) Toll-like receptor 4 is required for \u03b1-synuclein dependent activation of microglia and astroglia. Glia 61(3):349\u201360. https:\/\/doi.org\/10.1002\/glia.22437","journal-title":"Glia"},{"key":"4584_CR136","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1038\/srep01393","volume":"3","author":"C Noelker","year":"2013","unstructured":"Noelker C et al (2013) Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease. Sci Rep 3:1393. https:\/\/doi.org\/10.1038\/srep01393","journal-title":"Sci Rep"},{"issue":"10","key":"4584_CR137","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.tips.2012.07.002","volume":"33","author":"J Drouin-Ouellet","year":"2012","unstructured":"Drouin-Ouellet J, Cicchetti F (2012) Inflammation and neurodegeneration: the story \u201cretolled.\u201d Trends Pharmacol Sci 33(10):542\u201351. https:\/\/doi.org\/10.1016\/j.tips.2012.07.002","journal-title":"Trends Pharmacol Sci"},{"issue":"11","key":"4584_CR138","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","volume":"73","author":"XY Qin","year":"2016","unstructured":"Qin XY et al (2016) Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis. JAMA Neurol 73(11):1316\u20131324. https:\/\/doi.org\/10.1001\/jamaneurol.2016.2742","journal-title":"JAMA Neurol"},{"issue":"6","key":"4584_CR139","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1111\/j.1471-4159.2010.06879.x","volume":"114","author":"RF Villar\u00e1n","year":"2010","unstructured":"Villar\u00e1n RF et al (2010) Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson`s disease. J Neurochem 114(6):1687\u2013700. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06879.x","journal-title":"J Neurochem"},{"issue":"4","key":"4584_CR140","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S et al (2019) Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron 103(4):627-641.e7. https:\/\/doi.org\/10.1016\/j.neuron.2019.05.035","journal-title":"Neuron"},{"issue":"7","key":"4584_CR141","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/emmm.201302475","volume":"5","author":"A Ulusoy","year":"2013","unstructured":"Ulusoy A et al (2013) Caudo-rostral brain spreading of \u03b1-synuclein through vagal connections. EMBO Mol Med 5(7):1119\u201327. https:\/\/doi.org\/10.1002\/emmm.201302475","journal-title":"EMBO Mol Med"},{"key":"4584_CR142","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jneuroim.2016.01.007","volume":"291","author":"E Caggiu","year":"2016","unstructured":"Caggiu E et al (2016) Humoral cross reactivity between \u03b1-synuclein and herpes simplex-1 epitope in Parkinson\u2019s disease, a triggering role in the disease? J Neuroimmunol 291:110\u20134. https:\/\/doi.org\/10.1016\/j.jneuroim.2016.01.007","journal-title":"J Neuroimmunol"},{"issue":"7","key":"4584_CR143","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.parkreldis.2014.02.031","volume":"20","author":"JM Woulfe","year":"2014","unstructured":"Woulfe JM et al (2014) Hypothesis: a role for EBV-induced molecular mimicry in Parkinson\u2019s disease. Parkinsonism Relat Disord 20(7):685\u201394. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.02.031","journal-title":"Parkinsonism Relat Disord"},{"key":"4584_CR144","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fcimb.2015.00033","volume":"5","author":"JD Taylor","year":"2015","unstructured":"Taylor JD, Matthews SJ (2015) New insight into the molecular control of bacterial functional amyloids. Front Cell Infect Microbiol 5:33. https:\/\/doi.org\/10.3389\/fcimb.2015.00033","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"4584_CR145","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/cells8030222","volume":"8","author":"F Miraglia","year":"2019","unstructured":"Miraglia F, Colla E (2019) Microbiome. Parkinson\u2019s disease and molecular mimicry. Cells 8(3):222. https:\/\/doi.org\/10.3390\/cells8030222","journal-title":"Parkinson's disease and molecular mimicry. Cells"},{"key":"4584_CR146","doi-asserted-by":"publisher","unstructured":"Eicher TP, Mohajeri MH (2022) Overlapping mechanisms of action of brain-active bacteria and bacterial metabolites in the pathogenesis of common brain diseases. Nutrients 14(13):2661. https:\/\/doi.org\/10.3390\/nu14132661","DOI":"10.3390\/nu14132661"},{"issue":"11","key":"4584_CR147","doi-asserted-by":"publisher","first-page":"G1288","DOI":"10.1152\/ajpgi.00341.2012","volume":"303","author":"Y Asano","year":"2012","unstructured":"Asano Y et al (2012) Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am J Physiol Gastrointest Liver Physiol 303(11):G1288-95. https:\/\/doi.org\/10.1152\/ajpgi.00341.2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"4584_CR148","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12974-023-02693-1","volume":"20","author":"J Ma","year":"2023","unstructured":"Ma J et al (2023) 5-HT attenuates chronic stress-induced cognitive impairment in mice through intestinal flora disruption. J Neuroinflammation 20(1):23. https:\/\/doi.org\/10.1186\/s12974-023-02693-1","journal-title":"J Neuroinflammation"},{"issue":"38","key":"4584_CR149","doi-asserted-by":"publisher","first-page":"16050","DOI":"10.1073\/pnas.1102999108","volume":"108","author":"JA Bravo","year":"2011","unstructured":"Bravo JA et al (2011) Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 108(38):16050\u20135. https:\/\/doi.org\/10.1073\/pnas.1102999108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"4584_CR150","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.euroneuro.2017.12.004","volume":"28","author":"OF O'Leary","year":"2018","unstructured":"O\u2019Leary OF et al (2018) The vagus nerve modulates BDNF expression and neurogenesis in the hippocampus. Eur Neuropsychopharmacol 28(2):307\u2013316. https:\/\/doi.org\/10.1016\/j.euroneuro.2017.12.004","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"4584_CR151","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","volume":"161","author":"JM Yano","year":"2015","unstructured":"Yano JM et al (2015) Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161(2):264\u201376. https:\/\/doi.org\/10.1016\/j.cell.2015.02.047","journal-title":"Cell"},{"issue":"10","key":"4584_CR152","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.bbagen.2012.05.012","volume":"1820","author":"T Audhya","year":"2012","unstructured":"Audhya T, Adams JB, Johansen L (2012) Correlation of serotonin levels in CSF, platelets, plasma, and urine. Biochim Biophys Acta 1820(10):1496\u2013501. https:\/\/doi.org\/10.1016\/j.bbagen.2012.05.012","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"4584_CR153","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00221-001-0979-3","volume":"143","author":"M Bianchi","year":"2002","unstructured":"Bianchi M et al (2002) Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes. Exp Brain Res 143(2):191\u20137. https:\/\/doi.org\/10.1007\/s00221-001-0979-3","journal-title":"Exp Brain Res"},{"key":"4584_CR154","doi-asserted-by":"publisher","first-page":"105314","DOI":"10.1016\/j.parkreldis.2023.105314","volume":"108","author":"JY Wang","year":"2023","unstructured":"Wang JY et al (2023) Reduced platelet 5-HT content is associated with rest tremor in Parkinson\u2019s disease. Parkinsonism Relat Disord 108:105314. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105314","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"4584_CR155","doi-asserted-by":"publisher","first-page":"e0183509","DOI":"10.1371\/journal.pone.0183509","volume":"12","author":"E Aarts","year":"2017","unstructured":"Aarts E et al (2017) Gut microbiome in ADHD and its relation to neural reward anticipation. PLoS One 12(9):e0183509. https:\/\/doi.org\/10.1371\/journal.pone.0183509","journal-title":"PLoS One"},{"issue":"1","key":"4584_CR156","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.gtc.2016.09.007","volume":"46","author":"TG Dinan","year":"2017","unstructured":"Dinan TG, Cryan JF (2017) The microbiome-gut-brain axis in health and disease. Gastroenterol Clin North Am 46(1):77\u201389. https:\/\/doi.org\/10.1016\/j.gtc.2016.09.007","journal-title":"Gastroenterol Clin North Am"},{"issue":"7682","key":"4584_CR157","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature24661","volume":"551","author":"D Dodd","year":"2017","unstructured":"Dodd D et al (2017) A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature 551(7682):648\u2013652. https:\/\/doi.org\/10.1038\/nature24661","journal-title":"Nature"},{"key":"4584_CR158","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jnutbio.2019.03.021","volume":"69","author":"S Srivastav","year":"2019","unstructured":"Srivastav S et al (2019) Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity. J Nutr Biochem 69:73\u201386. https:\/\/doi.org\/10.1016\/j.jnutbio.2019.03.021","journal-title":"J Nutr Biochem"},{"issue":"3","key":"4584_CR159","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.clnu.2018.05.018","volume":"38","author":"OR Tamtaji","year":"2019","unstructured":"Tamtaji OR et al (2019) Clinical and metabolic response to probiotic administration in people with Parkinson\u2019s disease: a randomized, double-blind, placebo-controlled trial. Clin Nutr 38(3):1031\u20131035. https:\/\/doi.org\/10.1016\/j.clnu.2018.05.018","journal-title":"Clin Nutr"},{"issue":"12","key":"4584_CR160","doi-asserted-by":"publisher","first-page":"e0244680","DOI":"10.1371\/journal.pone.0244680","volume":"15","author":"A Ibrahim","year":"2020","unstructured":"Ibrahim A et al (2020) Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson\u2019s disease: a randomised controlled trial. PLoS One 15(12):e0244680. https:\/\/doi.org\/10.1371\/journal.pone.0244680","journal-title":"PLoS One"},{"issue":"5","key":"4584_CR161","doi-asserted-by":"publisher","first-page":"e772","DOI":"10.1212\/wnl.0000000000010998","volume":"96","author":"AH Tan","year":"2021","unstructured":"Tan AH et al (2021) Probiotics for constipation in Parkinson disease: a randomized placebo-controlled study. Neurology 96(5):e772\u2013e782. https:\/\/doi.org\/10.1212\/wnl.0000000000010998","journal-title":"Neurology"},{"key":"4584_CR162","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","volume":"70","author":"MF Sun","year":"2018","unstructured":"Sun MF et al (2018) Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson\u2019s disease mice: gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway. Brain Behav Immun 70:48\u201360. https:\/\/doi.org\/10.1016\/j.bbi.2018.02.005","journal-title":"Brain Behav Immun"},{"issue":"26","key":"4584_CR163","doi-asserted-by":"publisher","first-page":"e16163","DOI":"10.1097\/md.0000000000016163","volume":"98","author":"H Huang","year":"2019","unstructured":"Huang H et al (2019) Fecal microbiota transplantation to treat Parkinson\u2019s disease with constipation: a case report. Medicine (Baltimore) 98(26):e16163. https:\/\/doi.org\/10.1097\/md.0000000000016163","journal-title":"Medicine (Baltimore)"},{"key":"4584_CR164","doi-asserted-by":"publisher","first-page":"106791","DOI":"10.1016\/j.clineuro.2021.106791","volume":"207","author":"A Segal","year":"2021","unstructured":"Segal A et al (2021) Fecal microbiota transplant as a potential treatment for Parkinson\u2019s disease - a case series. Clin Neurol Neurosurg 207:106791. https:\/\/doi.org\/10.1016\/j.clineuro.2021.106791","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"4584_CR165","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12934-021-01589-0","volume":"20","author":"XY Kuai","year":"2021","unstructured":"Kuai XY et al (2021) Evaluation of fecal microbiota transplantation in Parkinson\u2019s disease patients with constipation. Microb Cell Fact 20(1):98. https:\/\/doi.org\/10.1186\/s12934-021-01589-0","journal-title":"Microb Cell Fact"},{"key":"4584_CR166","doi-asserted-by":"publisher","first-page":"1104759","DOI":"10.3389\/fneur.2023.1104759","volume":"14","author":"HL DuPont","year":"2023","unstructured":"DuPont HL et al (2023) Fecal microbiota transplantation in Parkinson\u2019s disease-a randomized repeat-dose, placebo-controlled clinical pilot study. Front Neurol 14:1104759. https:\/\/doi.org\/10.3389\/fneur.2023.1104759","journal-title":"Front Neurol"},{"issue":"2","key":"4584_CR167","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/cells9020376","volume":"9","author":"T Hegelmaier","year":"2020","unstructured":"Hegelmaier T et al (2020) Interventional influence of the intestinal microbiome through dietary intervention and bowel cleansing might improve motor symptoms in Parkinson\u2019s disease. Cells 9(2):376. https:\/\/doi.org\/10.3390\/cells9020376","journal-title":"Cells"},{"issue":"1","key":"4584_CR168","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41531-024-00681-7","volume":"10","author":"D Kwon","year":"2024","unstructured":"Kwon D et al (2024) Diet and the gut microbiome in patients with Parkinson\u2019s disease. npj Parkinson\u2019s Disease 10(1):89. https:\/\/doi.org\/10.1038\/s41531-024-00681-7","journal-title":"npj Parkinson's Disease"},{"issue":"1","key":"4584_CR169","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1021\/acs.jafc.1c06998","volume":"70","author":"J Liu","year":"2022","unstructured":"Liu J et al (2022) Effect of coffee against MPTP-induced motor deficits and neurodegeneration in mice via regulating gut microbiota. J Agric Food Chem 70(1):184\u2013195. https:\/\/doi.org\/10.1021\/acs.jafc.1c06998","journal-title":"J Agric Food Chem"},{"key":"4584_CR170","doi-asserted-by":"publisher","first-page":"887407","DOI":"10.3389\/fcimb.2022.887407","volume":"12","author":"C Cui","year":"2022","unstructured":"Cui C et al (2022) Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson\u2019s disease. Front Cell Infect Microbiol 12:887407. https:\/\/doi.org\/10.3389\/fcimb.2022.887407","journal-title":"Front Cell Infect Microbiol"},{"key":"4584_CR171","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.bbi.2021.02.028","volume":"94","author":"H Jeon","year":"2021","unstructured":"Jeon H et al (2021) Korean red ginseng suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced inflammation in the substantia nigra and colon. Brain Behav Immun 94:410\u2013423. https:\/\/doi.org\/10.1016\/j.bbi.2021.02.028","journal-title":"Brain Behav Immun"},{"key":"4584_CR172","doi-asserted-by":"publisher","first-page":"8381870","DOI":"10.1155\/2022\/8381870","volume":"2022","author":"J Li","year":"2022","unstructured":"Li J et al (2022) Effect of berberine hydrochloride on the diversity of intestinal flora in Parkinson\u2019s disease patients. Contrast Media Mol Imaging 2022:8381870. https:\/\/doi.org\/10.1155\/2022\/8381870","journal-title":"Contrast Media Mol Imaging"},{"issue":"5","key":"4584_CR173","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/0964528421990658","volume":"39","author":"QQ Han","year":"2021","unstructured":"Han QQ et al (2021) Electroacupuncture may alleviate behavioral defects via modulation of gut microbiota in a mouse model of Parkinson\u2019s disease. Acupunct Med 39(5):501\u2013511. https:\/\/doi.org\/10.1177\/0964528421990658","journal-title":"Acupunct Med"},{"key":"4584_CR174","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbi.2020.08.015","volume":"89","author":"JH Jang","year":"2020","unstructured":"Jang JH et al (2020) Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson\u2019s disease. Brain Behav Immun 89:641\u2013655. https:\/\/doi.org\/10.1016\/j.bbi.2020.08.015","journal-title":"Brain Behav Immun"},{"issue":"1","key":"4584_CR175","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s12967-022-03551-z","volume":"20","author":"H Ning","year":"2022","unstructured":"Ning H et al (2022) Zishen pingchan granules combined with pramipexole in the improvement of depressive symptoms in Parkinson\u2019s disease: a prospective, multicenter, randomized, double-blind, controlled clinical study. J Transl Med 20(1):357. https:\/\/doi.org\/10.1186\/s12967-022-03551-z","journal-title":"J Transl Med"},{"issue":"3","key":"4584_CR176","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1142\/s0192415x21500282","volume":"49","author":"ST Feng","year":"2021","unstructured":"Feng ST et al (2021) Efficacy of traditional Chinese medicine combined with selective serotonin reuptake inhibitors on the treatment for Parkinson\u2019s disease with depression: a systematic review and meta-analysis. Am J Chin Med 49(3):627\u2013643. https:\/\/doi.org\/10.1142\/s0192415x21500282","journal-title":"Am J Chin Med"},{"key":"4584_CR177","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.prdoa.2019.07.006","volume":"1","author":"R Krikorian","year":"2019","unstructured":"Krikorian R et al (2019) Nutritional ketosis for mild cognitive impairment in Parkinson\u2019s disease: A controlled pilot trial. Clin Park Relat Disord 1:41\u201347. https:\/\/doi.org\/10.1016\/j.prdoa.2019.07.006","journal-title":"Clin Park Relat Disord"},{"issue":"10","key":"4584_CR178","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s12603-018-1094-5","volume":"22","author":"P Agarwal","year":"2018","unstructured":"Agarwal P et al (2018) MIND diet associated with reduced incidence and delayed progression of Parkinsonism in old age. J Nutr Health Aging 22(10):1211\u20131215. https:\/\/doi.org\/10.1007\/s12603-018-1094-5","journal-title":"J Nutr Health Aging"},{"issue":"6","key":"4584_CR179","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/1028415x.2017.1294555","volume":"21","author":"P Perez-Pardo","year":"2018","unstructured":"Perez-Pardo P et al (2018) Gut-brain and brain-gut axis in Parkinson\u2019s disease models: effects of a uridine and fish oil diet. Nutr Neurosci 21(6):391\u2013402. https:\/\/doi.org\/10.1080\/1028415x.2017.1294555","journal-title":"Nutr Neurosci"},{"issue":"7","key":"4584_CR180","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1136\/gutjnl-2019-319654","volume":"69","author":"TS Ghosh","year":"2020","unstructured":"Ghosh TS et al (2020) Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries. Gut 69(7):1218\u20131228. https:\/\/doi.org\/10.1136\/gutjnl-2019-319654","journal-title":"Gut"},{"key":"4584_CR181","doi-asserted-by":"publisher","first-page":"4134931","DOI":"10.1155\/2022\/4134931","volume":"2022","author":"Z Wang","year":"2022","unstructured":"Wang Z et al (2022) The effect of the integrated Chinese and Western medicine for the treatment of Parkinson\u2019s disease: a meta-analysis. Comput Math Methods Med 2022:4134931. https:\/\/doi.org\/10.1155\/2022\/4134931","journal-title":"Comput Math Methods Med"},{"issue":"5483","key":"4584_CR182","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1126\/science.289.5483.1352","volume":"289","author":"L Steidler","year":"2000","unstructured":"Steidler L et al (2000) Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289(5483):1352\u20135. https:\/\/doi.org\/10.1126\/science.289.5483.1352","journal-title":"Science"},{"issue":"6","key":"4584_CR183","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.cgh.2006.03.028","volume":"4","author":"H Braat","year":"2006","unstructured":"Braat H et al (2006) A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn\u2019s disease. Clin Gastroenterol Hepatol 4(6):754\u20139. https:\/\/doi.org\/10.1016\/j.cgh.2006.03.028","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"4584_CR184","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1093\/brain\/awaa201","volume":"143","author":"Y Qian","year":"2020","unstructured":"Qian Y et al (2020) Gut metagenomics-derived genes as potential biomarkers of Parkinson\u2019s disease. Brain 143(8):2474\u20132489. https:\/\/doi.org\/10.1093\/brain\/awaa201","journal-title":"Brain"},{"issue":"1","key":"4584_CR185","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.dld.2018.09.017","volume":"51","author":"F Zhu","year":"2019","unstructured":"Zhu F et al (2019) The risk of Parkinson\u2019s disease in inflammatory bowel disease: a systematic review and meta-analysis. Dig Liver Dis 51(1):38\u201342. https:\/\/doi.org\/10.1016\/j.dld.2018.09.017","journal-title":"Dig Liver Dis"},{"issue":"8","key":"4584_CR186","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1001\/jamaneurol.2018.0605","volume":"75","author":"I Peter","year":"2018","unstructured":"Peter I et al (2018) Anti-tumor necrosis factor therapy and incidence of Parkinson disease among patients with inflammatory bowel disease. JAMA Neurol 75(8):939\u2013946. https:\/\/doi.org\/10.1001\/jamaneurol.2018.0605","journal-title":"JAMA Neurol"},{"issue":"3","key":"4584_CR187","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1007\/s00415-021-10688-2","volume":"269","author":"SY Yoon","year":"2022","unstructured":"Yoon SY et al (2022) Irritable bowel syndrome and subsequent risk of Parkinson\u2019s disease: a nationwide population-based matched-cohort study. J Neurol 269(3):1404\u20131412. https:\/\/doi.org\/10.1007\/s00415-021-10688-2","journal-title":"J Neurol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04584-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04584-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04584-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:08:44Z","timestamp":1741064924000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04584-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":187,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["4584"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04584-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,12]]},"assertion":[{"value":"5 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}